Neurology India
menu-bar5 Open access journal indexed with Index Medicus
  Users online: 508  
 Home | Login 
About Editorial board Articlesmenu-bullet NSI Publicationsmenu-bullet Search Instructions Online Submission Subscribe Videos Etcetera Contact
  Navigate Here 
    Next article
    Previous article
    Table of Contents

 Resource Links
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded0    
    Comments [Add]    
    Cited by others 1    

Recommend this journal


Year : 1998  |  Volume : 46  |  Issue : 2  |  Page : 102--104

Gabapentin in refractory partial seizures.

Department of Neurology, Govt. General Hospital, Madras - 600 003, India

Correspondence Address:
M Dhanaraj
Department of Neurology, Govt. General Hospital, Madras - 600 003
Login to access the Email id

Source of Support: None, Conflict of Interest: None

PMID: 29508795

Rights and PermissionsRights and Permissions

We report our preliminary observations on the role of Gabapentin as an add - on therapy in 16 patients with partial or secondary generalised seizures who were resistant to conventional antiepileptic drugs. There was a reduction in the seizure frequency by more than 50 in 11 (69), less than 50 in 3 (18.75), and increase in 1 (6.25). Adverse effects were noted in 9 (56.25 ) of them. The giddiness and sleepiness was seen in 5 (31.25 ); in one it was so severe that he withdrew from the study. Ataxic gait was observed in 1 (6.25). Reduction in the haemoglobin by 2 gms. occurred in 2 (12.5) and asymptomatic eosinophilia in 1 (6.25). As an add - on drug, the efficacy of Gabapentin was good. Regular haematological monitoring is necessary while the patients are on the drug. Further studies involving large number of patients in our country is necessary.

[PDF Not available]*

Print this article     Email this article

Online since 20th March '04
Published by Wolters Kluwer - Medknow